These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6934422)

  • 1. Leprosy in Auckland.
    Lang WR
    N Z Med J; 1980 Oct; 92(669):271-5. PubMed ID: 6934422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-drug therapy in bacilliferous leprosy--two years experience.
    Kaur S; Sharma VK; Kumar B; Singh M; Kaur I
    Indian J Lepr; 1985; 57(3):483-90. PubMed ID: 3831085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of multidrug therapy on the treatment and control of leprosy.
    Gilbody JS
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):458-78. PubMed ID: 1890370
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field application of combined therapy for infectious leprosy cases. A feasibility study in Bombay.
    Ganapati R; Revankar CR; Naik SS
    Lepr India; 1983 Jul; 55(3):485-9. PubMed ID: 6656206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined treatments consisting of rifampicin in periodic doses: the experience in Niger].
    Soga G; Blanc L; Alfa C; Grosset J; Xavier S
    Acta Leprol; 1986; 4(4):397-407. PubMed ID: 3296609
    [No Abstract]   [Full Text] [Related]  

  • 8. A overview of ocular leprosy after 2 decades of multidrug therapy.
    Lewallen S; Courtright P
    Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
    [No Abstract]   [Full Text] [Related]  

  • 9. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Hansen's disease.
    Alto WA
    Am Fam Physician; 2002 Apr; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412
    [No Abstract]   [Full Text] [Related]  

  • 11. Problems of leprosy relapse in China.
    Li HY
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofazimine and dapsone compliance in leprosy.
    Ellard GA; Pannikar VK; Jesudasan K; Christian M
    Lepr Rev; 1988 Sep; 59(3):205-13. PubMed ID: 3200085
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 15. [Leprosy and the nervous system (author's transl)].
    Hentschel B
    Nervenarzt; 1979 Jun; 50(6):346-51. PubMed ID: 224331
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring dapsone self-administration in a multidrug therapy programme.
    van Asbeck-Raat AM; Becx-Bleumink M
    Lepr Rev; 1986 Jun; 57(2):121-7. PubMed ID: 3747704
    [No Abstract]   [Full Text] [Related]  

  • 17. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
    Mysore V; al-Suwaid AR
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):159-61. PubMed ID: 10472369
    [No Abstract]   [Full Text] [Related]  

  • 19. Hansen's disease in Portugal: multibacillary patients treated between 1988 and 2003.
    Medeiros S; Catorze MG; Vieira MR
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):29-35. PubMed ID: 18713227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug therapy in leprosy.
    Manglani PR; Arif MA
    J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.